![Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-6715-g05.jpg)
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma
![Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-6715-g06.jpg)
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma
![Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5835aee9687d11160fd503ad0ecb876e36789aca/3-Table3-1.png)
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
![International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120619760-gr1.jpg)
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
![The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study | Cancer Cell International | Full Text The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-022-02772-y/MediaObjects/12935_2022_2772_Fig1_HTML.png)
The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study | Cancer Cell International | Full Text
![NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients | British Journal of Cancer NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2016.325/MediaObjects/41416_2016_Article_BFbjc2016325_Fig1_HTML.jpg)
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients | British Journal of Cancer
![Immunohistochemical double hit score enhances NCCN–IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma - Prochazka - 2018 - British Journal of Haematology - Immunohistochemical double hit score enhances NCCN–IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma - Prochazka - 2018 - British Journal of Haematology -](https://onlinelibrary.wiley.com/cms/asset/6dfe7ebe-f122-4d43-8b0c-d74e48328f66/bjh14912-fig-0001-m.jpg)
Immunohistochemical double hit score enhances NCCN–IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma - Prochazka - 2018 - British Journal of Haematology -
![Five-year OS for low vs high NCCN-IPI risk groups (A) and according to... | Download Scientific Diagram Five-year OS for low vs high NCCN-IPI risk groups (A) and according to... | Download Scientific Diagram](https://www.researchgate.net/publication/337228585/figure/fig1/AS:824944212574210@1573693435502/Five-year-OS-for-low-vs-high-NCCN-IPI-risk-groups-A-and-according-to-hemoglobin-Hgb.png)
Five-year OS for low vs high NCCN-IPI risk groups (A) and according to... | Download Scientific Diagram
![An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. - Abstract - Europe PMC An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5527396/bin/837f2.jpg)
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. - Abstract - Europe PMC
![We applied the model of (A) NCCN-IPI in our study. Compared with (B)... | Download Scientific Diagram We applied the model of (A) NCCN-IPI in our study. Compared with (B)... | Download Scientific Diagram](https://www.researchgate.net/publication/268155176/figure/fig4/AS:601692458450968@1520466069923/We-applied-the-model-of-A-NCCN-IPI-in-our-study-Compared-with-B-the-original-IPI.png)
We applied the model of (A) NCCN-IPI in our study. Compared with (B)... | Download Scientific Diagram
![Table 4 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar Table 4 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5835aee9687d11160fd503ad0ecb876e36789aca/4-Table4-1.png)